MSCI Inc
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-22 04:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 10-Q | 2026-10-20 | Read on SEC.gov |
| 8-K | 2026-10-20 | Read on SEC.gov |
| 8-K | 2026-08-07 | Read on SEC.gov |
| 10-Q | 2026-07-21 | Read on SEC.gov |
| 8-K | 2026-07-21 | Read on SEC.gov |
| 8-K | 2026-04-23 | Read on SEC.gov |
| 10-Q | 2026-04-21 | Read on SEC.gov |
| 8-K | 2026-04-21 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-22 07:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $3.13B | Annual | 2025-12-31 | 2026-02-06 | 10-K |
| Net income | $1.20B | Annual | 2025-12-31 | 2026-02-06 | 10-K |
| Operating cash flow | $1.59B | Annual | 2025-12-31 | 2026-02-06 | 10-K |
| Total assets | $5.70B | As of | 2025-12-31 | 2026-02-06 | 10-K |
| Total liabilities | $8.36B | As of | 2025-12-31 | 2026-02-06 | 10-K |
| Stockholders’ equity | $-2.65B | As of | 2025-12-31 | 2026-02-06 | 10-K |
| Cash and cash equivalents | $515.33M | As of | 2025-12-31 | 2026-02-06 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 5.97, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
- Index is the largest reported line at 59.71% of revenue, across 4 reported segments.
- Analytics follows at 21.41%, so the top line still matters most but isn’t the whole story.
Revenue annual, last 8 years
Latest year +9.75% YoY
Margins
- Gross margin
- 82.44%
- Operating margin
- 54.67%
- Net margin
- 38.36%
Key ratios & quality
- PEG ratioi
- 2.84
- Altman Z-Scorei
- 5.97
PEG uses trailing P/E against the 3-year net income growth rate (11.36%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.43B | 1.56B | 1.70B | 2.04B | 2.25B | 2.53B | 2.86B | 3.13B |
| Gross profit | 1.15B | 1.26B | 1.40B | 1.68B | 1.84B | 2.08B | 2.34B | 2.58B |
| Selling & admin expenses | 292.81M | 329.39M | 331.12M | 391.08M | 411.44M | 430.17M | 473.56M | 500.05M |
| Research & development | 81.41M | 98.33M | 101.05M | 111.56M | 107.21M | 132.12M | 158.65M | 177.60M |
| Operating profit | 686.90M | 755.70M | 884.76M | 1.09B | 1.21B | 1.38B | 1.53B | 1.71B |
| Pretax profit | 629.90M | 603.32M | 686.23M | 858.14M | 1.04B | 1.37B | 1.36B | 1.49B |
| Tax | 122.01M | 39.67M | 84.40M | 132.15M | 173.27M | 220.47M | 247.04M | 291.95M |
| Net profit | 507.89M | 563.65M | 601.82M | 725.98M | 870.57M | 1.15B | 1.11B | 1.20B |
| Basic EPS | 6 | 7 | 7 | 9 | 11 | 14 | 14 | 16 |
| Diluted EPS | 5.66 | 6.59 | 7.12 | 8.70 | 10.72 | 14.39 | 14.05 | 15.69 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 772.70M | 793.40M | 822.56M | 850.80M | 867.00M | 892.00M |
| Gross profit | 635.00M | 660.90M | 679.19M | 709.00M | 717.10M | 739.80M |
| Selling & admin expenses | 116.50M | 121.70M | 126.05M | 154.70M | 133.60M | 138.40M |
| Research & development | 44.10M | 44.80M | 41.10M | 49.60M | 46.00M | 47.60M |
| Operating profit | 425.30M | 447.60M | 463.67M | 456.90M | 487.50M | 502.10M |
| Pretax profit | 377.80M | 396.50M | 388.86M | 389.20M | 417.30M | 427.90M |
| Tax | 74.10M | 71.20M | 104.15M | -16.80M | 75.30M | 76.90M |
| Net profit | 303.70M | 325.30M | 284.71M | 406.00M | 342.00M | 351.00M |
| Basic EPS | 4 | 4 | 4 | 6 | 5 | 5 |
| Diluted EPS | 3.92 | 4.25 | 3.81 | 5.53 | 4.69 | 4.86 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.44B | 2.08B | 1.93B | 2.14B | 1.75B | 1.42B | 1.34B | 1.64B |
| Cash & ST investments | 904.18M | 1.51B | 1.30B | 1.42B | 993.20M | 457.82M | 405.85M | 511.67M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 3.39B | 4.20B | 4.20B | 5.51B | 5.00B | 5.52B | 5.45B | 5.70B |
| Total current liabilities | 809.01M | 900.79M | 1.02B | 1.25B | 1.25B | 1.52B | 1.59B | 1.83B |
| Short-term debt | -- | -- | -- | -- | 8.71M | 10.90M | -- | -- |
| Long-term debt | 2.58B | 3.07B | 3.37B | 4.16B | 4.50B | 4.50B | 4.51B | 6.20B |
| Total liabilities | 3,554,446,000.00 | 4,281,153,000.00 | 4,641,881,000.00 | 5,670,170,000.00 | 6,005,460,000.00 | 6,257,983,000.00 | 6,385,436,000.00 | 8,356,999,000.00 |
| Total equity | -166.49M | -76.71M | -443.23M | -163.47M | -1.01B | -739.76M | -940.00M | -2.65B |
| Retained earnings | 1.86B | 2.20B | 2.55B | 2.98B | 3.47B | 4.18B | 4.78B | 5.43B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 1.27B | 1.31B | 1.64B | 1.39B | 1.44B | 1.30B |
| Cash & ST investments | 343.68M | 396.43M | 511.67M | 381.70M | 352.70M | 257.40M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.37B | 5.39B | 5.70B | 5.55B | 5.60B | 5.60B |
| Total current liabilities | 1.47B | 1.48B | 1.83B | 1.61B | 1.61B | 1.57B |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 4.51B | 5.51B | 6.20B | 6.40B | 6.38B | 6.72B |
| Total liabilities | 6,259,884,000.00 | 7,305,115,000.00 | 8,356,999,000.00 | 8,319,400,000.00 | 8,292,000,000.00 | 8,611,700,000.00 |
| Total equity | -886.21M | -1.92B | -2.65B | -2.77B | -2.69B | -3.02B |
| Retained earnings | 5.09B | 5.28B | 5.43B | 5.68B | 5.88B | 6.08B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 612.76M | 709.52M | 811.11M | 936.07M | 1.10B | 1.24B | 1.50B | 1.59B |
| Depreciation & amortization | 85.54M | 101.90M | 110.80M | 134.13M | 142.50M | 159.22M | 206.28M | 218.57M |
| Free cash flow | 563.80M | 655.75M | 760.13M | 883.28M | 1.02B | 1.15B | 1.39B | 1.46B |
| Dividends paid | -170.94M | -222.92M | -246.44M | -302.45M | -372.92M | -440.99M | -509.11M | -556.52M |
| Stock buybacks / issuance | -949.89M | -292.08M | -778.52M | -198.37M | -1.40B | -504.19M | -885.27M | -2.48B |
| Ending cash balance | 904.18M | 1.51B | 1.30B | 1.42B | 993.56M | 461.69M | 409.35M | 515.33M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 336.20M | 449.40M | 501.15M | 306.80M | 370.80M | 436.10M |
| Depreciation & amortization | 55.30M | 53.20M | 55.57M | 54.60M | 57.50M | 59.40M |
| Free cash flow | 301.70M | 423.20M | 464.89M | 278.00M | 326.40M | 385.40M |
| Dividends paid | -139.70M | -137.90M | -135.12M | -150.50M | -149.50M | -147.80M |
| Stock buybacks / issuance | -138.50M | -1.23B | -906.81M | -414.80M | -168.40M | -552.60M |
| Ending cash balance | 347.30M | 400.10M | 515.33M | 385.30M | 356.40M | 261.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 433.13 | -- | -- | -- | -- | -- | -- | -- |
| ROA %i | 15.24 | 14.85 | 14.32 | 14.96 | 16.58 | 21.85 | 20.23 | 21.57 |
| ROIC %i | 24.52 | -- | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | 119.72 | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 53.21 | 48.23 | 49.70 | 49.80 | 54.05 | 61.52 | 53.98 | 54.37 |
| FCF / sales %i | 39.32 | 42.09 | 44.84 | 43.22 | 45.47 | 45.28 | 48.55 | 46.53 |
| Current ratioi | 1.77 | 2.31 | 1.88 | 1.71 | 1.40 | 0.93 | 0.85 | 0.90 |
| Quick ratioi | 1.70 | 2.23 | 1.82 | 1.67 | 1.32 | 0.86 | 0.77 | 0.82 |
| Debt / assetsi | 76.02 | 76.97 | 83.82 | 78.29 | 92.92 | 83.87 | 85.06 | 110.65 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 5.73 | 5.08 | 5.39 | 6.38 | 7.08 | 8.33 | 8.31 | 8.12 |
| Revenue CAGR (3Y) %i | 10.08 | 10.63 | 9.99 | 12.53 | 13.01 | 14.26 | 11.81 | 11.71 |
| Net income CAGR (3Y) %i | 31.44 | 29.28 | 25.57 | 12.65 | 15.59 | 24.04 | 15.17 | 11.36 |
| FCF CAGR (3Y) %i | 27.49 | 17.94 | 28.85 | 16.14 | 15.96 | 14.64 | 16.22 | 12.57 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 21.77 | 22.66 | 21.57 | 24.24 | 24.74 | 25.19 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 54.04 | 54.35 | 54.37 | 55.10 | 55.47 | 55.41 |
| FCF / sales %i | 45.51 | 45.44 | 46.53 | 45.31 | 44.77 | 42.38 |
| Current ratioi | 0.86 | 0.88 | 0.90 | 0.86 | 0.89 | 0.82 |
| Quick ratioi | 0.77 | 0.77 | 0.82 | 0.78 | 0.77 | 0.71 |
| Debt / assetsi | 86.13 | 104.27 | 110.65 | 118.08 | 116.36 | 122.71 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 8.73 | 8.66 | 8.12 | 7.68 | 7.19 | 6.83 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 20:02:21 · For reference only, not investment advice and not tailored to your situation.
MSCI Inc discussion 0 comments